95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
100.00%
Revenue growth above 1.5x OR's 9.92%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
100.00%
Gross profit growth above 1.5x OR's 10.18%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
64.36%
EBIT growth above 1.5x OR's 15.15%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
64.36%
Operating income growth above 1.5x OR's 7.56%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
87.32%
Net income growth above 1.5x OR's 26.20%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
87.33%
EPS growth above 1.5x OR's 21.43%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
87.33%
Diluted EPS growth above 1.5x OR's 21.43%. David Dodd would see if there's a robust moat protecting these shareholder gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-292.20%
Negative OCF growth while OR is at 11.49%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-292.20%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-100.00%
Negative 10Y revenue/share CAGR while OR stands at 191.83%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-100.00%
Negative 5Y CAGR while OR stands at 29.95%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-100.00%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1164.16%
Negative 3Y OCF/share CAGR while OR stands at 22738.42%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1370.88%
Negative 3Y CAGR while OR is 86.14%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-7.08%
Negative asset growth while OR invests at 3.85%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-4.75%
We have a declining book value while OR shows 5.86%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
110.89%
SG&A growth well above OR's 19.74%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.